GAP (Bermuda) L.P.

Insider Reports History

Location
New York, NY
Signature
/s/ Michael Gosk
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by GAP (Bermuda) L.P.:

Form 4 holding Director, 10%+ Owner

Centessa Pharmaceuticals plc

Security class
Share Option (right to buy)
Shares / value
48,000
Estimated value
Report date
22 Jun 2023
Price
Ownership
Indirect
Underlying class
Ordinary Shares
Underlying amount

Insider Reports Filed by GAP (Bermuda) L.P.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .